Announcements

  • Antiviral Agent Lowers CMV Risk in Stem Cell Transplant

    8 years ago
    The antiviral drug (Prevymis) helped prevent cytomegalovirus in patients with donor bone marrow stem cell transplantation compared with patients who received placebo, a phase III clinical trial found.